Skip to main content
. 2009 Jul 1;297(3):F662–F670. doi: 10.1152/ajprenal.00146.2009

Fig. 2.

Fig. 2.

Activation of ERK1/2 in renal medulla of Sprague-Dawley rats after 5,14-20-HEDE treatment. A: representative Western blot depicting ERK1/2 activation after 5,14-20-HEDE (HEDE) treatment (30 mg/kg sc). p-ERK1/2, phosphorylated ERK1/2; CONT, control. B: p-ERK1/2 densitometry (n = 4 individual animals). **Significant difference from control (P < 0.01).